Fever of unknown origin, muscle weakness, and an adrenal nodule—the cat we chased like a hare: a case report Authors: Amanda Hillesheim Schuck, Isadora Martins da Silva Stumpf, Alessandro Batista Soares, Laura Brasil Mittmann, Janine Alessi Published: 2025 ABSTRACT AbstractBackgroundFever of unknown origin remains a significant clinical challenge in hospitalized patients worldwide. In this report, we describe a case of fever of unknown origin in which the principal radiological finding was an adrenal nodule exhibiting a hyperintense signal on contrast-enhanced T2-weighted magnetic resonance imaging. While such description is characteristic of pheochromocytoma or malignant adrenal lesions, this report aims to explore alternative diagnostic considerations in light of the clinical context.Case presentationA 70-year-old white male Brazilian was admitted to a university hospital for investigation of persistent fever and lack of response to systemic antibiotic therapy. He reported experiencing daily episodes of evening fever, reaching up to 39 °C, for approximately 6 months. He also experienced significant unintentional weight loss of approximately 15 kg, accompanied by progressive asthenia that evolved into marked lower limb weakness (muscle strength grade 4 in lower limbs, deep reflexes preserved). An extensive infectious investigation was performed: serial blood, urine, and otologic secretion cultures were repeatedly negative. Transesophageal echocardiography excluded infectious endocarditis. Screening for rheumatologic disease, including Antinuclear antibodies, anti-cyclic citrullinated peptide antibodies, anti-neutrophil cytoplasmic antibody, and screening for antiphospholipid syndrome were negative. Subsequent abdominal magnetic resonance imaging identified a 0.7 cm left adrenal nodule with T2 hyperintensity and arterial/venous enhancement. A diagnostic adrenalectomy was performed, and histopathological analysis revealed necrotizing vasculitis with thrombosis of peri-adrenal fat vessels, accompanied by lymphocytic and neutrophilic infiltrates, without granulomas or giant cells—findings consistent with vasculitis, most compatible with polyarteritis nodosa. Following an extensive diagnostic workup by the clinical team, the patient achieved full recovery after treatment with high-dose pulse corticosteroid therapy and immunosuppressive agent.ConclusionsThis case report underscores the critical importance of continuously revisiting diagnostic hypotheses in complex cases, maintaining vigilance for atypical and uncommon etiologies to prevent misdiagnosis and delays in appropriate therapy.Supplementary InformationThe online version contains supplementary material available at 10.1186/s13256-025-05656-7.Keywords: Adrenal vasculitis, Fever of unknown origin, Polyarteritis nodosa, Polyneuropathy, Case report Background Fever of unknown origin (FUO) is frequently a clinical challenge in patients hospitalized worldwide. A previous prevalence study, including 21 countries, found that most common diagnoses were infections (51.6%), neoplasms (11.4%), and collagen vascular diseases (9.3%). Interestingly, about 21% of causes of FUO went undefined [1]. Although unusual, some adrenal gland diseases may also be a cause of FUO, as in adrenal insufficiency or in IL-6-producing pheochromocytomas [2]. The objective of this report is to present a case of FUO in which the principal radiological finding was an adrenal nodule exhibiting a hyperintense signal on contrast-enhanced T2-weighted magnetic resonance imaging. While such description is characteristic of pheochromocytoma or malignant adrenal lesions, this report aims to explore alternative diagnostic considerations in light of the clinical context. By examining this case, we seek to underscore the importance of maintaining a broad differential diagnosis and to illustrate that radiologic features, although suggestive, may not be always pathognomonic. Case presentation A 70-year-old white male Brazilian was admitted to a university hospital in southern Brazil for investigation of persistent fever and lack of response to systemic antibiotics. He reported experiencing daily episodes of evening fever around 39 °C for approximately 6 months, accompanied by profuse sweating, significant unintentional weight loss of approximately 15 kg, and progressive asthenia. The patient had no cardiopulmonary symptoms, arthralgia, lymphadenopathy, or other gastrointestinal complaints. He had recently performed an outpatient evaluation (upper endoscopy, screening colonoscopy, and prostate evaluation), all with normal results. He had a past medical history of treated and cured pulmonary tuberculosis in 1980. He was not taking any chronic medications and had no history of smoking, drinking, or using other drugs. He denied recently traveling outside of his region, and there were no endemic diseases associated with his symptomatology where he lives. At the physical exam, he was in a fair general condition, was febrile, and had notable cachexia. No palpable lymphadenopathy was detected. A neurological examination revealed muscle strength grade 4 in lower limbs. No focal neurological deficits or sensory impairment were observed, and the deep reflexes were preserved. Cardiac and pulmonary auscultation were normal, and abdominal examination was within normal limits. No signs of joint inflammation or cutaneous or other inflammatory manifestations were found upon ectoscopy (Supplementary Fig. S1). An aggressive workup for infectious disease was performed, and serial hemocultures, urine, and tracheal secretion samples cultures were consistently negative. Laboratory results revealed normocytic and normochromic anemia, consistent with chronic inflammation, and mild leukocytosis (Table 1). The inflammatory markers were raised (C-reactive protein 21.6 mg/L, erythrocyte sedimentation rate 112 mm/hour). Inflammatory myopathies were considered to be due to progressive muscle weakness. Muscle enzymes (CK and aldolase) were within normal ranges, as were the myositis-associated autoantibodies. The full panel of investigations performed is available in Supplementary Table S1. Table 1Results of the main initial laboratory testsLaboratory examResultReference rangeComplete blood countHemoglobin: 8.4 g/dL12.8–17.8 g/dLWhite blood cell count: 19610/µL3600–11000/µLNeutrophils: 16472/µL1500–7900/µLLymphocytes: 1530/µL1000–5500/µLPlatelet count: 635000/µL150000–450000/µLCreatinine0.53 mg/dL0.70–1.20 mg/dLSodium128 mEq/L137–145.0 mEq/LPotassium4.5 mEq/L3.5–5.1 mEq/LSerum lactate dehydrogenase212.0 U/L120–246.0 U/LTotal bilirubin0.4 mg/dL0–1.3 mg/dLAspartate aminotransferase23 U/L17–59.0 U/LAlanine aminotransferase41 U/L0–50.0 U/LHIV 1/2-antigen and antibody testingNonreactive/index 0.15Nonreactive: < 0.9 UI/LHBsAgNonreactive/index 0.26Non-reactive: < 0.9 UI/LTotal anti-HBCNonreactive/index 0.76Index < 0.90: nonreactiveAnti-hepatitis C virusNonreactive/index 0.11Nonreactive: < 0.9 UI/LC-reactive protein21.6 mg/dL < 1.0 mg/dLErythrocyte sedimentation rate103.0 mm/hour0–15.0 mm/hourANANonreactiveNonreactiveC3 complement113 mg/dL90–170 mg/dLC4 complement14 mg/dL12–36 mg/dLRheumatoid factor115.8 UI/mL (sample dilution 1:10) ≤ 14.00 UI/mLAnti-CCPNonreactiveNonreactiveAnti-SSANonreactiveNonreactiveAnti-SSBNonreactiveNonreactiveAnti-JoNonreactiveNonreactiveAnti-cardiolipin IgGNonreactiveNonreactiveAnti-cardiolipin IgM17.7 MPLNonreactive: < 12.5 MPL; Indeterminate: 12.5–20 MPL; Reactive: > 20 MPLLupic anticoagulantNegativeNegativeP-ANCANonreactiveNonreactiveC-ANCAReactive 1:20NonreactiveAnti-PR33 UR/mLNonreactive: < 20 UR/mLAnti-MPO2 UR/mLNonreactive: < 20 UR/mLAnti-SRPNon-detectableNon-detectableCK < 20 U/L55.0–170.0 U/LAldolase5.1 U/L ≤ 7.6 U/LProtein electrophoresis*Monoclonal protein: nonmeasurableAbsentSerum protein immunofixationAbsence of monoclonal proteinAbsentHIV human immunodeficiency virus, HBsAg hepatitis B surface antigen, Total anti-HBC total antibodies to hepatitis B core antigen, ANA antinuclear antibodies, anti-CCP anti-cyclic citrullinated peptide, anti-SSA anti–Sjögren’s-syndrome-related antigen A autoantibodies, Anti-SSB anti–Sjögren’s-syndrome-related antigen B autoantibodies, Anti-Jo autoantibodies targeting the histidyl tRNA synthetase enzyme; ANCA anti-neutrophil cytoplasm antibodies autoantibodies, anti-SRP anti-signal recognition particle (autoantibodies associated with a specific type of idiopathic inflammatory myopathy), anti-PR3 antibodies against proteinase 3 (an enzyme found in neutrophils), anti-MPO antibodies against myeloperoxidase (an enzyme found in the granules of neutrophils and monocytes), CK creatine phosphokinase*The complete list of all laboratory tests performed during the investigation is provided in the Supplementary Material Results of the main initial laboratory tests HIV human immunodeficiency virus, HBsAg hepatitis B surface antigen, Total anti-HBC total antibodies to hepatitis B core antigen, ANA antinuclear antibodies, anti-CCP anti-cyclic citrullinated peptide, anti-SSA anti–Sjögren’s-syndrome-related antigen A autoantibodies, Anti-SSB anti–Sjögren’s-syndrome-related antigen B autoantibodies, Anti-Jo autoantibodies targeting the histidyl tRNA synthetase enzyme; ANCA anti-neutrophil cytoplasm antibodies autoantibodies, anti-SRP anti-signal recognition particle (autoantibodies associated with a specific type of idiopathic inflammatory myopathy), anti-PR3 antibodies against proteinase 3 (an enzyme found in neutrophils), anti-MPO antibodies against myeloperoxidase (an enzyme found in the granules of neutrophils and monocytes), CK creatine phosphokinase *The complete list of all laboratory tests performed during the investigation is provided in the Supplementary Material Magnetic resonance imaging (MRI) was requested, which showed an adrenal nodule of 0.8 cm, which was hyperintense in the T2 sequence, and which demonstrated arterial/venous wash-in and washout, concerning for pheochromocytoma or neoplastic disease (Supplementary Fig. S2). A diagnostic adrenalectomy was performed, and the histopathologic findings showed a necrotizing vasculitis with thrombosis in peri-adrenal fat vessels accompanied by lymphocytic and neutrophilic infiltrates and segmental fibrinoid necrosis of the vascular walls, without granulomas or giant cells, leading to the diagnosis of polyarteritis nodosa (PAN) (Fig. 1). Left adrenal gland: macroscopic aspects and histopathological findings. A Macroscopic view of the left adrenal gland specimen, resected via videolaparoscopic surgery, presented with usual dimensions and weighed 17 g. Arrowhead A(1) corresponds to the nodular lesion identified in imaging studies; a nodule measuring 1.0 × 0.8 cm was observed, located in the adrenal medulla topography. B Histopathological examination of the adrenal gland revealed preserved epithelial architecture, with focal areas showing necrotic vessels and thrombosis. Arrowhead B(1) indicates an intravascular thrombus corresponding to the topography of the nodule identified in section A(1). C In the periglandular tissue, an altered vessel was observed, characterized by a markedly eosinophilic wall surrounded by a neutrophil-rich inflammatory infiltrate involving almost the entire thickness of the medial layer in C(1). Segmental fibrinoid necrosis of the vascular wall is evident in C(2). In certain regions, the fibrinoid material extends in the direction of the perivascular tissue, imparting an appearance classically described as a “candle flame,” in C(3). D In the periglandular adipose tissue, a mixed lymphocytic and neutrophilic infiltrate is noted, involving the vessel wall and extending into the intimal layer in D(1). Most vascular lesions are segmental and do not compromise the entire circumference; accordingly, area D(2) illustrates a portion of the unaffected vessel. A prominent accumulation of neutrophils and lymphocytes is present within the adventitia and adjacent tissues Pulse therapy with methylprednisolone was initiated (total dose of 3 g), followed by maintenance therapy with prednisone at a dosage of 1 mg/kg/day. This intervention led to a marked improvement in muscle strength and resolution of febrile episodes. On the basis of these findings, azathioprine was initiated with progressive titration up to 100 mg/day, while prednisone was gradually tapered. Discussion and conclusion We described a case of a male patient with FUO, muscle weakness, and an adrenal nodule on MRI with T2 hyperintensity, in which the investigation workup led to the diagnosis of PAN vasculitis with adrenal involvement. PAN is a medium-sized systemic vasculitis characterized by nonspecific symptoms such as fever, weight loss, myalgia, and arthralgia. Some frequently encountered specific manifestations including cutaneous ones (such as nodules, livedo reticularis, and purpura), and kidney involvement [3]. In our patient, the presence of adrenal involvement and muscle weakness was the cardinal manifestation of PAN. The association between adrenal involvement and PAN is well known but rare. If the adrenal arteries are involved in the inflammatory process, this may result in adrenal infarction, bleeding, or, less commonly, ischemic necrosis of the gland. In most cases, they are asymptomatic and discovered incidentally on imaging or at autopsy [4]. Myalgia, sometimes accompanied by muscle weakness, is relatively common in PAN. In a systematic review, the percentage with perivascular inflammation in muscle biopsy was greater than 90% in PAN, and the presence of fibrinoid necrosis of the vessel walls was approximately 67% on biopsy specimens. Nevertheless, true myositis seems less frequent, indicating that nonspecific myalgia or mild muscle involvement are more common than overt myositis [5]. In this case report, a definitive diagnosis of PAN was reached after an extensive diagnostic investigation, and full recovery was obtained by treatment with high-dose pulse corticosteroid therapy with immunosuppressive agents. The complexity of FUO is illustrated in this case, where a FUO causes progressive clinical decline, but ultimately results in dramatic improvement in patient care when the diagnosis is established. It emphasizes the importance of maintaining a broad differential diagnosis and timely etiologic investigation to avoid treatment delays. Supplementary Information Additional file 1. Acknowledgements We thank Dr. Giordani Passos, neurologist, for conducting the neurological investigation. We are also grateful to Dr. Andrei Centeno, urologist, for performing the adrenalectomy and providing the surgical images. We extend our appreciation to the Pathology Institute of Porto Alegre for performing the pathology analysis and supplying the histological images. Abbreviations Polyarteritis nodosa Fever of unknown origin Author contributions AH Schuck and IMS Stumpf: case presentation report; AB Soares and LB Mittmann: background, and discussion; J Alessi: conceptualization, supervision, and final review. Funding None. Data availability JA is the guarantor of this study and, as such, has full access to all the data and takes responsibility for the integrity and accuracy of the data. Declarations Ethics approval and consent to participate The study was performed in accordance with the Helsinki Declaration (2004), followed all relevant guidelines and regulations. The patient assigned the informed consent form. All authors signed the confidentiality document for data use. The patient provided signed informed consent form. Consent for publication Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. Competing interests No potential conflict of interest was reported by the authors. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Additional file 1. Data Availability Statement JA is the guarantor of this study and, as such, has full access to all the data and takes responsibility for the integrity and accuracy of the data.